The use of cefiderocol for extensively drug-resistant gram-negative bacterial infections: a case series

被引：0
|
作者：
Sadyrbaeva-Dolgova, S. [1 ]
Martin-Roldan, A. [1 ]
Espinosa-Rodriguez, A. [1 ]
Jimenez-Morles, A. [1 ]
Hidalgo-Tenorio, C. [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2022年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PP177
引用
收藏
页码：1553 / 1554
页数：2
相关论文
共 50 条
  • [1] Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
    Zhou, Li
    Feng, Shanglong
    Sun, Guangyu
    Tang, Baolin
    Zhu, Xiaoyu
    Song, Kaidi
    Zhang, Xuhan
    Lu, Huaiwei
    Liu, Huilan
    Sun, Zimin
    Zheng, Changcheng
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 481 - 491
  • [2] Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria
    Iosifidis, Elias
    Violaki, Asimenia
    Michalopoulou, Evangelia
    Volakli, Elena
    Diamanti, Elisavet
    Koliouskas, Dimitrios
    Antachopoulos, Charalampos
    Drossou-Agakidou, Vasiliki
    Sdougka, Maria
    Roilides, Emmanuel
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 (02) : 123 - 128
  • [3] Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
    Gavaghan, Victoria
    Miller, Jessica L.
    Dela-Pena, Jennifer
    [J]. INFECTION, 2023, 51 (02) : 475 - 482
  • [4] Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
    Victoria Gavaghan
    Jessica L. Miller
    Jennifer Dela-Pena
    [J]. Infection, 2023, 51 : 475 - 482
  • [5] The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
    Reynolds, Daniel
    Burnham, Jason P.
    Guillamet, Cristina Vazquez
    McCabe, Mikaela
    Yuenger, Valerie
    Betthauser, Kevin
    Micek, Scott T.
    Kollef, Marin H.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166):
  • [6] Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
    Prinz, Carolin
    Streit, Frank
    Schumann, Christian
    Dudakova, Anna
    Lanckohr, Christian
    Schanz, Julie
    Bohn, Matthias
    Gross, Uwe
    Meissner, Konrad
    Moerer, Onnen
    Harnisch, Lars-Olav
    [J]. CLINICAL DRUG INVESTIGATION, 2023, 43 (04) : 307 - 314
  • [7] Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
    Carolin Prinz
    Frank Streit
    Christian Schumann
    Anna Dudakova
    Christian Lanckohr
    Julie Schanz
    Matthias Bohn
    Uwe Groß
    Konrad Meissner
    Onnen Moerer
    Lars-Olav Harnisch
    [J]. Clinical Drug Investigation, 2023, 43 (4) : 307 - 314
  • [8] Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
    Syed, Yahiya Y.
    [J]. DRUGS, 2021, 81 (13) : 1559 - 1571
  • [9] Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
    Yahiya Y. Syed
    [J]. Drugs, 2021, 81 : 1559 - 1571
  • [10] Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
    Parsels, Katie A.
    Mastro, Keri A.
    Steele, Jeffrey M.
    Thomas, Stephen J.
    Kufel, Wesley D.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1379 - 1391
12345